Bone density in proton pump inhibitors users: a prospective study

Drug-induced Osteoporosis: Mechanisms and Clinical Implications

(2010) Gherardo Mazziotti et al.   AMERICAN JOURNAL OF MEDICINE

Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women

(2010) Shelly L. Gray   ARCHIVES OF INTERNAL MEDICINE

Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients

(2010) Douglas A. Corley et al.   GASTROENTEROLOGY

Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice

(2010) B. McGowan et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

(2009) Laura E. Targownik et al.   GASTROENTEROLOGY

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates

(2009) F. de Vries et al.   OSTEOPOROSIS INTERNATIONAL

Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults

(2008) Elaine W. Yu et al.   CALCIFIED TISSUE INTERNATIONAL

Use of proton pump inhibitors and risk of osteoporosis-related fractures

(2008) L. E. Targownik et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL